1. Home /
  2. Drug Approvals

Drug Approvals

Jim Cramer: The President's Behavior Towards Covid-19

I know that Trump's going to blunt our community mask initiative because who needs masks if it isn't a big deal if you are sick?

Shark Bites: Positioning for a Positive Catalyst in Aurinia Pharmaceuticals

AUPH has two very large market opportunities for its voclosporin drug.

The Investment Angle of Covid-19

Stocks of companies that have Covid-19 vaccine candidates have boomed while those in the treatment space have not.

2 Dinged Biotech Stocks That Could Reward Investors in the Months Ahead

Shares of Heron Therapeutics and Myovant Sciences have taken hits but both companies still show promise.

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.

Want to Inject Some Growth Into Your Portfolio? Try This Dividend Stock

Pfizer is a quality dividend stock that's now trading at a discount.

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

RedHill Biopharma has adopted 'Veeva Vault CDMS', Veeva's modern cloud platform.

Here Are 2 Small Biotech Names Where I'm Using My Simple Covered Call Strategy

Let's dig into Strongbridge Biopharma and Agenus.

Stock-Specific Ideas for the Post-Fed Era of Investing

Make sure that your portfolio is composed of sane assets for the balance of this crazy year.

This Dividend Stock's Got the Right Medicine for Investors

AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector.